Pure Global AI
NCT06146335Not yet recruiting

Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery

Weill Medical College of Cornell UniversityClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Kono-S anastomosis (KSa)
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Weill Medical College of Cornell University
Location
New York, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Dec 01, 2035
Enrollment
80 participants
Primary outcome

Changes in composition of the microbiome between treatment groups,Changes in the immune cell environment between treatment groups

Summary

The purpose of this study is to compare the effect of two procedures - the Kono-S procedure
 and the side-to-side functional end to end anastomosis - on the microbiome (the bacteria that
 live in our gut) and on the intestinal immune system. The investigators are hypothesizing
 that there are differences in the microbiome environment and the immune environment between
 the two procedural groups.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06146335
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06146335 through Pure Global AI's free database. This phase not specified trial is sponsored by Weill Medical College of Cornell University and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.